433 related articles for article (PubMed ID: 26716896)
1. Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma.
Ji N; Weng D; Liu C; Gu Z; Chen S; Guo Y; Fan Z; Wang X; Chen J; Zhao Y; Zhou J; Wang J; Ma D; Li N
Oncotarget; 2016 Jan; 7(4):4369-78. PubMed ID: 26716896
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial.
Westphal M; Ylä-Herttuala S; Martin J; Warnke P; Menei P; Eckland D; Kinley J; Kay R; Ram Z;
Lancet Oncol; 2013 Aug; 14(9):823-33. PubMed ID: 23850491
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
[TBL] [Abstract][Full Text] [Related]
4. Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses.
Sandmair AM; Loimas S; Puranen P; Immonen A; Kossila M; Puranen M; Hurskainen H; Tyynelä K; Turunen M; Vanninen R; Lehtolainen P; Paljärvi L; Johansson R; Vapalahti M; Ylä-Herttuala S
Hum Gene Ther; 2000 Nov; 11(16):2197-205. PubMed ID: 11084677
[TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir.
Smitt PS; Driesse M; Wolbers J; Kros M; Avezaat C
Mol Ther; 2003 Jun; 7(6):851-8. PubMed ID: 12788659
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated gene therapy of experimental gliomas.
Perez-Cruet MJ; Trask TW; Chen SH; Goodman JC; Woo SL; Grossman RG; Shine HD
J Neurosci Res; 1994 Nov; 39(4):506-11. PubMed ID: 7884826
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus/herpes simplex-thymidine kinase/ganciclovir complex: preliminary results of a phase I trial in patients with recurrent malignant gliomas.
Germano IM; Fable J; Gultekin SH; Silvers A
J Neurooncol; 2003 Dec; 65(3):279-89. PubMed ID: 14682378
[TBL] [Abstract][Full Text] [Related]
8. Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study.
Harsh GR; Deisboeck TS; Louis DN; Hilton J; Colvin M; Silver JS; Qureshi NH; Kracher J; Finkelstein D; Chiocca EA; Hochberg FH
J Neurosurg; 2000 May; 92(5):804-11. PubMed ID: 10794295
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.
Eck SL; Alavi JB; Alavi A; Davis A; Hackney D; Judy K; Mollman J; Phillips PC; Wheeldon EB; Wilson JM
Hum Gene Ther; 1996 Aug; 7(12):1465-82. PubMed ID: 8844206
[TBL] [Abstract][Full Text] [Related]
10. AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study.
Immonen A; Vapalahti M; Tyynelä K; Hurskainen H; Sandmair A; Vanninen R; Langford G; Murray N; Ylä-Herttuala S
Mol Ther; 2004 Nov; 10(5):967-72. PubMed ID: 15509514
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitization of rat glioma with bromodeoxycytidine and adenovirus expressing herpes simplex virus-thymidine kinase delivered by slow, rate-controlled positive pressure infusion.
Brust D; Feden J; Farnsworth J; Amir C; Broaddus WC; Valerie K
Cancer Gene Ther; 2000 May; 7(5):778-88. PubMed ID: 10830725
[TBL] [Abstract][Full Text] [Related]
12. Double-Dose Adenovirus-Mediated Adjuvant Gene Therapy Improves Liver Transplantation Outcomes in Patients with Advanced Hepatocellular Carcinoma.
Zhu R; Weng D; Lu S; Lin D; Wang M; Chen D; Lv J; Li H; Lv F; Xi L; Zhou J; Ma D; Li N
Hum Gene Ther; 2018 Feb; 29(2):251-258. PubMed ID: 29446997
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma.
Kieran MW; Goumnerova L; Manley P; Chi SN; Marcus KJ; Manzanera AG; Polanco MLS; Guzik BW; Aguilar-Cordova E; Diaz-Montero CM; DiPatri AJ; Tomita T; Lulla R; Greenspan L; Aguilar LK; Goldman S
Neuro Oncol; 2019 Mar; 21(4):537-546. PubMed ID: 30883662
[TBL] [Abstract][Full Text] [Related]
14. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J
Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.
Trask TW; Trask RP; Aguilar-Cordova E; Shine HD; Wyde PR; Goodman JC; Hamilton WJ; Rojas-Martinez A; Chen SH; Woo SL; Grossman RG
Mol Ther; 2000 Feb; 1(2):195-203. PubMed ID: 10933931
[TBL] [Abstract][Full Text] [Related]
16. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
17. In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.
Herman JR; Adler HL; Aguilar-Cordova E; Rojas-Martinez A; Woo S; Timme TL; Wheeler TM; Thompson TC; Scardino PT
Hum Gene Ther; 1999 May; 10(7):1239-49. PubMed ID: 10340555
[TBL] [Abstract][Full Text] [Related]
18. Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.
Xu F; Li S; Li XL; Guo Y; Zou BY; Xu R; Liao H; Zhao HY; Zhang Y; Guan ZZ; Zhang L
Cancer Gene Ther; 2009 Sep; 16(9):723-30. PubMed ID: 19363470
[TBL] [Abstract][Full Text] [Related]
19. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group.
Shand N; Weber F; Mariani L; Bernstein M; Gianella-Borradori A; Long Z; Sorensen AG; Barbier N
Hum Gene Ther; 1999 Sep; 10(14):2325-35. PubMed ID: 10515452
[TBL] [Abstract][Full Text] [Related]
20. Transduction of a fiber-mutant adenovirus for the HSVtk gene highly augments the cytopathic effect towards gliomas.
Shinoura N; Sakurai S; Asai A; Kirino T; Hamada H
Jpn J Cancer Res; 2000 Oct; 91(10):1028-34. PubMed ID: 11050474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]